OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures
OrganOx to benefit from Intuitive Ventures’ and Terumo Ventures’ unique operating and clinical experience
OrganOx has completed a second closing of its private placement with investments from Intuitive Ventures, Terumo Ventures, and Piper Heartland Healthcare LLC. Together with the first closing of its private placement on February 24, 2025, OrganOx raised $160 million in primary and secondary equity financing to accelerate growth opportunities for its metra® platform technology in the large and high growth organ technology global market.